Horizon Bancorp’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-135
Closed -$12K 210
2022
Q4
$12K Buy
+135
New +$11.4K 0.01% 172
2020
Q3
$327K Buy
3,763
+163
+5% +$14.1K 0.46% 58
2020
Q2
$314K Sell
3,600
-856
-19% -$73.9K 0.34% 56
2020
Q1
$367K Sell
4,456
-319
-7% -$28.5K 0.57% 50
2019
Q4
$452K Buy
+4,775
New +$428K 0.42% 63

Other funds holding NVS

Horizon Bancorp's NVS Position: Q1 2023 in Review

Horizon Bancorp sold out of Novartis (NVS) in Q1 2023, closing a stake of 135 shares — an estimated $12K sold.

Horizon Bancorp first reported a position in NVS in Q4 2019 and held it in 5 quarters. The position peaked at $452K in Q4 2019. 1,180 funds tracked by Wall St. Rank hold NVS as of Q1 2023.

  • Horizon Bancorp reported no remaining Novartis position as of Q1 2023 after selling out during the quarter.
  • Horizon Bancorp sold 135 Novartis shares in Q1 2023, an estimated $12K.
  • Horizon Bancorp first reported a position in Novartis in Q4 2019 and held it in 5 quarters.
  • Horizon Bancorp's Novartis position peaked at $452K in Q4 2019.
  • 1,180 funds tracked by Wall St. Rank held Novartis as of Q1 2023.

Based on Horizon Bancorp's 13F filing for Q1 2023, filed 5 May 2023.